Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O75460 2081 ERN1 IRE1 Ovarian cancer Phosphorylation N T49 O75460 2081 ERN1 IRE1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K95 O75460 2081 ERN1 IRE1 Stomach adenocarcinoma Ubiquitination N K374 O75460 2081 ERN1 IRE1 Pancreatic adenocarcinoma Phosphorylation N S533 O75460 2081 ERN1 IRE1 Head and neck squamous cell carcinoma Phosphorylation N S548 O75460 2081 ERN1 IRE1 Head and neck squamous cell carcinoma Phosphorylation N S551 O75460 2081 ERN1 IRE1 Pancreatic adenocarcinoma Phosphorylation N S551 O75460 2081 ERN1 IRE1 Brain lower grade glioma Phosphorylation N Y628 O75460 2081 ERN1 IRE1 Skin cutaneous melanoma Phosphorylation N Y628 O75460 2081 ERN1 IRE1 Brain lower grade glioma Ubiquitination N K633 O75460 2081 ERN1 IRE1 Gastric adenocarcinoma Ubiquitination N K633 O75460 2081 ERN1 IRE1 Skin cutaneous melanoma Ubiquitination N K633 O75460 2081 ERN1 IRE1 Breast invasive carcinoma Ubiquitination N K706 O75460 2081 ERN1 IRE1 Lung adenocarcinoma Phosphorylation N S724 O75460 2081 ERN1 IRE1 Uterine corpus endometrial carcinoma Phosphorylation N S724 O75460 2081 ERN1 IRE1 Lung adenocarcinoma Phosphorylation N S726 O75460 2081 ERN1 IRE1 Uterine corpus endometrial carcinoma Phosphorylation N S726 O75460 2081 ERN1 IRE1 Lung adenocarcinoma Phosphorylation N S729 O75460 2081 ERN1 IRE1 Uterine corpus endometrial carcinoma Phosphorylation N S729 O75460 2081 ERN1 IRE1 Bladder urothelial carcinoma Ubiquitination N K851 O75460 2081 ERN1 IRE1 Bladder urothelial carcinoma Ubiquitination N K860 Q9NZJ5 9451 EIF2AK3 PEK PERK Prostate adenocarcinoma Ubiquitination N K452 Q9NZJ5 9451 EIF2AK3 PEK PERK Head and neck squamous cell carcinoma Phosphorylation N S555 Q9NZJ5 9451 EIF2AK3 PEK PERK Breast adenocarcinoma Ubiquitination N K581 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Ubiquitination N K581 Q9NZJ5 9451 EIF2AK3 PEK PERK Breast adenocarcinoma Phosphorylation N Y585 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N Y585 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison syndrome Phosphorylation N Y585 Q9NZJ5 9451 EIF2AK3 PEK PERK Stomach adenocarcinoma Phosphorylation N Y619 Q9NZJ5 9451 EIF2AK3 PEK PERK Ovarian serous cystadenocarcinoma Ubiquitination N K622 Q9NZJ5 9451 EIF2AK3 PEK PERK Stomach adenocarcinoma Ubiquitination N K622 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N S688 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N S694 Q9NZJ5 9451 EIF2AK3 PEK PERK Stomach adenocarcinoma Phosphorylation N T705 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N T705 Q9NZJ5 9451 EIF2AK3 PEK PERK Bladder urothelial carcinoma Phosphorylation N S715 Q9NZJ5 9451 EIF2AK3 PEK PERK Stomach adenocarcinoma Phosphorylation N S715 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N S715 Q9NZJ5 9451 EIF2AK3 PEK PERK Bladder urothelial carcinoma Phosphorylation N S719 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N S719 Q9NZJ5 9451 EIF2AK3 PEK PERK Breast adenocarcinoma Phosphorylation N T802 Q9NZJ5 9451 EIF2AK3 PEK PERK Head and neck squamous cell carcinoma Phosphorylation N T802 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung adenocarcinoma Phosphorylation N T802 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung squamous cell carcinoma Phosphorylation N T802 Q9NZJ5 9451 EIF2AK3 PEK PERK Head and neck squamous cell carcinoma Phosphorylation N S811 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung adenocarcinoma Phosphorylation N S811 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung squamous cell carcinoma Phosphorylation N S811 Q9NZJ5 9451 EIF2AK3 PEK PERK Pancreatic adenocarcinoma Phosphorylation N S811 Q9NZJ5 9451 EIF2AK3 PEK PERK Uterine corpus endometrial carcinoma Phosphorylation N S811 Q9NZJ5 9451 EIF2AK3 PEK PERK Colon adenocarcinoma Phosphorylation N S856 Q9NZJ5 9451 EIF2AK3 PEK PERK Hepatocellular carcinoma Phosphorylation N S856 Q9NZJ5 9451 EIF2AK3 PEK PERK Colon adenocarcinoma Phosphorylation N T861 Q9NZJ5 9451 EIF2AK3 PEK PERK Hepatocellular carcinoma Phosphorylation N T861 Q9NZJ5 9451 EIF2AK3 PEK PERK Colon adenocarcinoma Phosphorylation N T862 Q9NZJ5 9451 EIF2AK3 PEK PERK Hepatocellular carcinoma Phosphorylation N T862 Q9NZJ5 9451 EIF2AK3 PEK PERK Head and neck squamous cell carcinoma Phosphorylation N T982 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung adenocarcinoma Phosphorylation N T982 Q9NZJ5 9451 EIF2AK3 PEK PERK Non-Hodgkin's lymphoma Phosphorylation N T982 Q9NZJ5 9451 EIF2AK3 PEK PERK Wolcott-Rallison dysplasia Phosphorylation N T982 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung squamous cell carcinoma Phosphorylation N S1094 Q9NZJ5 9451 EIF2AK3 PEK PERK Skin cutaneous melanoma Phosphorylation N S1094 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung squamous cell carcinoma Phosphorylation N S1096 Q9NZJ5 9451 EIF2AK3 PEK PERK Skin cutaneous melanoma Phosphorylation N S1096 O75460 2081 ERN1 IRE1 Lung cancer lung cancer cell lines and tissues ADP-ribosylation D 38253797 Q9NZJ5 9451 EIF2AK3 PEK PERK Lung cancer lung cancer cell lines and tissues ADP-ribosylation D 38253797 O75460 2081 ERN1 IRE1 Neurological damage Phosphorylation U 24114795 Q9NZJ5 9451 EIF2AK3 PEK PERK Alzheimer's disease Phosphorylation P 24319643